These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35510373)

  • 41. Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma.
    Li H; Dutuor A; Tao L; Fu X; Zhang X
    Clin Cancer Res; 2007 Jan; 13(1):316-22. PubMed ID: 17200370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment.
    Keshavarz M; Ebrahimzadeh MS; Miri SM; Dianat-Moghadam H; Ghorbanhosseini SS; Mohebbi SR; Keyvani H; Ghaemi A
    Virol J; 2020 May; 17(1):64. PubMed ID: 32370750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncolytic herpes virus induces effective anti-cancer immunity against murine colon cancer.
    Shirota T; Kasuya H; Kodera Y; Nishikawa Y; Shikano T; Sahin TT; Gewen T; Yamamura K; Fukuda S; Kanzaki A; Yamada S; Fujii T; Sugimoto H; Nomoto S; Takeda S; Nakao A
    Hepatogastroenterology; 2011; 58(110-111):1482-9. PubMed ID: 21940320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced efficacy of herpes simplex virus mutant HF10 combined with paclitaxel in peritoneal cancer dissemination models.
    Shimoyama S; Goshima F; Teshigahara O; Kasuya H; Kodera Y; Nakao A; Nishiyama Y
    Hepatogastroenterology; 2007 Jun; 54(76):1038-42. PubMed ID: 17629034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of CCL19 from oncolytic vaccinia enhances immunotherapeutic potential while maintaining oncolytic activity.
    Li J; O'Malley M; Sampath P; Kalinski P; Bartlett DL; Thorne SH
    Neoplasia; 2012 Dec; 14(12):1115-21. PubMed ID: 23308044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted Delivery of IL-12 Adjuvants Immunotherapy by Oncolytic Viruses.
    Vannini A; Leoni V; Campadelli-Fiume G
    Adv Exp Med Biol; 2021; 1290():67-80. PubMed ID: 33559855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade.
    Nakao S; Arai Y; Tasaki M; Yamashita M; Murakami R; Kawase T; Amino N; Nakatake M; Kurosaki H; Mori M; Takeuchi M; Nakamura T
    Sci Transl Med; 2020 Jan; 12(526):. PubMed ID: 31941828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of colon cancer with oncolytic herpes simplex virus in preclinical models.
    Yang H; Peng T; Li J; Wang Y; Zhang W; Zhang P; Peng S; Du T; Li Y; Yan Q; Liu B
    Gene Ther; 2016 May; 23(5):450-9. PubMed ID: 26871935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncolytic virus as an agent for the treatment of malignant ascites.
    Liu HL; Chen J
    Cancer Biother Radiopharm; 2009 Feb; 24(1):99-102. PubMed ID: 19216627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus.
    Vigil A; Park MS; Martinez O; Chua MA; Xiao S; Cros JF; Martínez-Sobrido L; Woo SL; García-Sastre A
    Cancer Res; 2007 Sep; 67(17):8285-92. PubMed ID: 17804743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia.
    Wang W; Liu S; Dai P; Yang N; Wang Y; Giese RA; Merghoub T; Wolchok J; Deng L
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytotoxic T lymphocyte-associated protein 4 antibody aggrandizes antitumor immune response of oncolytic virus M1 via targeting regulatory T cells.
    Liu W; Liu Y; Hu C; Xu C; Chen J; Chen Y; Cai J; Yan G; Zhu W
    Int J Cancer; 2021 Sep; 149(6):1369-1384. PubMed ID: 34086978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1.
    Kim KJ; Moon D; Kong SJ; Lee YS; Yoo Y; Kim S; Kim C; Chon HJ; Kim JH; Choi KJ
    Gene Ther; 2021 Apr; 28(3-4):186-198. PubMed ID: 33149278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination.
    Pol JG; Bridle BW; Lichty BD
    Methods Mol Biol; 2020; 2058():191-211. PubMed ID: 31486039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites.
    Jennings VA; Ilett EJ; Scott KJ; West EJ; Vile R; Pandha H; Harrington K; Young A; Hall GD; Coffey M; Selby P; Errington-Mais F; Melcher AA
    Int J Cancer; 2014 Mar; 134(5):1091-101. PubMed ID: 23982804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo.
    Yin L; Zhao C; Han J; Li Z; Zhen Y; Xiao R; Xu Z; Sun Y
    Ther Clin Risk Manag; 2017; 13():117-130. PubMed ID: 28223815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody.
    Kanaya N; Kuroda S; Kakiuchi Y; Kumon K; Tsumura T; Hashimoto M; Morihiro T; Kubota T; Aoyama K; Kikuchi S; Nishizaki M; Kagawa S; Tazawa H; Mizuguchi H; Urata Y; Fujiwara T
    Mol Ther; 2020 Mar; 28(3):794-804. PubMed ID: 31991110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity.
    Yan Y; Li S; Jia T; Du X; Xu Y; Zhao Y; Li L; Liang K; Liang W; Sun H; Li R
    Tumour Biol; 2015 Jun; 36(6):4535-43. PubMed ID: 25627006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy.
    Shi G; Yang Q; Zhang Y; Jiang Q; Lin Y; Yang S; Wang H; Cheng L; Zhang X; Li Y; Wang Q; Liu Y; Wang Q; Zhang H; Su X; Dai L; Liu L; Zhang S; Li J; Li Z; Yang Y; Yu D; Wei Y; Deng H
    Mol Ther; 2019 Jan; 27(1):244-260. PubMed ID: 30527756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer.
    Francis L; Guo ZS; Liu Z; Ravindranathan R; Urban JA; Sathaiah M; Magge D; Kalinski P; Bartlett DL
    Oncotarget; 2016 Apr; 7(16):22174-85. PubMed ID: 26956047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.